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-C/S oniC sequLe~cee group.bmj.com on September 8, 2017 -Published by http://jmg.bmj.com/ Downloaded from residue in the first codon of exon 3. The mutation also destroys an RsaI site and thus RP patients may be screened quickly for the presence of the mutation by simple restriction analysis. The segregation of the mutation with the disease in this family is shown in fig 2. Codon 178 occurs in an intradiscal loop of rhodopsin which is implicated in determining normal rhodopsin tertiary structure.'0 It is likely that a mutation alters this structure, which in turn causes changes related to the pathogenesis of the disease.
The family also shows significantly decreased levels of certain polyunsaturated acids in the plasma of affected subjects compared to unaffected relatives.9 It is possible that a gene involved in the synthesis or transport of these fatty acids is linked to the rhodopsin gene.
Although the exact mechanism is unknown, knowledge of the actual mutation presents an opportunity for accurate counselling of affected persons.
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